Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by wildbird1on May 22, 2023 4:19pm
215 Views
Post# 35459320

RE:RE:The first 25 patients.

RE:RE:The first 25 patients.
99942Apophis wrote: Regardless of the original statement of the first 25 patients wildbird1,  something has changed or happened that might have altered that number.  We don't know if the FDA needs a slightly different data configuration for Theralase to receive BTD & AA which is what I believe might be in the works and would explain the extra time factor here. Honestly I don't care what the reason is or a little extra time I still am confident Theralase is a shining star and will get those designations. 
Stop watching that pot of water waiting for it to boil, its on high.
99942Apophis, thank's for your reply...,

In the last 3 financial,
August 29,2022.
Nov      29,2022.
April     26,2023.
When talking about the BTD update, TLT mentioned 25 patients every single time.
That is a good indication that the 25 patients number didn't change.

<< Previous
Bullboard Posts
Next >>